Wegovy solution for injection in pre-filled pen 0.25mg

• Patients should report signs and symptoms of pancreatitis such as severe stomach pain radiating to the back and if present, the treatment with semaglutide injection should be discontinued immediately. • Patients with a previous history of diabetic retinopat‍​‍‍‍​‍‍‍‍‍‍‍‍​‍hy should be monitored to check for the eye-related disease progression. • Treatment with semaglutide injection should be stopped immediately if a severe allergic reaction occurs and patients must be treated appropriately. • Semaglutide injection may cause a serious decrease in the blood sugar level when used along with other antidiabetic drugs, which may require a dose reduction. • Caution is required while using in patients with kidney disease and monitoring kidney function is necessary to avoid the complications.